Abstract: A public-private key cryptographic scheme is described for granting authenticating a client to a remote device or service in order to access a secure resource. The client is provided the public key, but the private key is stored in a hardware security module (HSM) that the client is not able to access. The client requests a digital signature be generated from the private key from a secure vault service. The secure vault service accesses the HSM and generates the digital certificate, which is then passed to the client. The digital certificate may be added to a security token request submitted to an identity provider. The identity provider determines whether the digital signature came from the private key.

Abstract: A public-private key cryptographic scheme is described for granting authenticating a client to a remote device or service in order to access a secure resource. The client is provided the public key, but the private key is stored in a hardware security module (HSM) that the client is not able to access. The client requests a digital signature be generated from the private key from a secure vault service. The secure vault service accesses the HSM and generates the digital certificate, which is then passed to the client. The digital certificate may be added to a security token request submitted to an identity provider. The identity provider determines whether the digital signature came from the private key.

Abstract: Data investigations are performed by querying a plurality of data sources. A system receives an investigation input and queries a plurality of data sources in accordance with the received input. The system receives, in response to the querying, response data from the plurality of data sources, and generates and stores a data structure representing relationships between the first investigation input and the first response data. The data structure may be in the form of a knowledge graph. The system may generate and display a visualization of the data structure. The system may generate and store a record of investigation steps used to generate the data structure, such that the investigation steps may be applied in future instances, for example using different inputs, to generate new data structures.

Abstract: A disclosed method of determining operating states of a fan uses a digital image of the fan and at least one operating parameter-specific algorithm. In a first stage, the method includes generating the digital image of the fan as a representation of the fan's properties, the representation based on one or more mathematical calculation models and optionally known data. The method further includes generating the at least one operating parameter-specific algorithm based on at least one of known relationships and characteristic curves, and calculating component states of the fan via the digital image, wherein the calculation of component states is based on virtual sensors. The method further includes generating a system behavior algorithm that calculates operating parameters of the fan based on the component states and optionally generates predictions relating to the operation of the fan.

Abstract: The present invention covers [(phenylsulfonyl)octahydro-epiminoisoindol-yl](1H-1,2,3-triazol-5-yl)methanone compounds of general formula (I), in which Q, R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of disorders, in particular of gynecological disorders, hyperproliferative disorders, metabolic disorders, or inflammatory disorders as a sole agent or in combination with other active ingredients.

Abstract: The present invention covers [4-(phenylsulfonyl)piperazin-1-yl](1H-1,2,3-triazol-4-yl)methanone compounds of general formula (I), in which Q, R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of disorders, in particular of gynecological disorders, hyperproliferative disorders, metabolic disorders, or inflammatory disorders as a sole agent or in combination with other active ingredients.

Abstract: The present invention covers [4-(phenylsulfonyl)piperazin-1-yl](1H-1,2,3-triazol-4-yl)methanone compounds of general formula (I): (I), in which Q, R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of disorders, in particular of gynecological disorders, hyperproliferative disorders, metabolic disorders, or inflammatory disorders as a sole agent or in combination with other active ingredients.

Abstract: The present application relates to the use of bicyclic-substituted uracil derivatives, alone or in combinations with other active ingredients for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of inflammatory and fibrotic disorders, for the treatment of endometriosis, of endometriosis-associated fibrosis, of adenomyosis and of pain associated with an endometriosis disorder and also of postoperative peritoneal fibrosis and adhesion formation.

Abstract: An illustrative elevator system includes an elevator car, a machine including a motor that provides a motive force for moving the elevator car along a travel path and a brake that resists movement of the elevator car, and a brake controller. The brake controller is configured to determine when the elevator car is within a selected range of at least one end of the travel path. The brake controller inhibits a delay in application of the brake when the elevator car is within the selected range and permits a delay in application of the brake when the elevator car is outside of the selected range.

Abstract: The present invention covers [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanone compounds of general formula (I): in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of disorders, in particular of gynecological disorders, hyperproliferative disorders, metabolic disorders, or inflammatory disorders as a sole agent or in combination with other active ingredients.

Abstract: The present invention relates to substituted Pyridyl-cycloalkyl-carboxylic acids of general formula (I), to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular in mammals, such as diseases associated with pains, or for the treatment or prophylaxis of pain syndromes (acute and chronic), inflammatory-induced pain, pelvic pain, cancer-associated pain, endometriosis-associated pain as well as endometriosis and adenomyosis as such, cancer as such, and proliferative diseases as such like endometriosis.

Abstract: The present invention covers [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanone compounds of general formula (I): in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of disorders, in particular of gynecological disorders, hyperproliferative disorders, metabolic disorders, or inflammatory disorders as a sole agent or in combination with other active ingredients.

Abstract: An embodiment implements a methodology for printing non-saturated text and lines in a way that removes the jagged edge problem. An embodiment uses a combination of two screens, e.g. AM screening and applying pure color. For example, according to the embodiment, the closer to the edge from the interior of text or lines, the less amplitude modulation half toning is applied and the more actual color or contone is applied. A particular algorithm for determining and using a blending parameter is provided.

Abstract: A drill bit has a shank portion having a plurality of SDS-type slots, a cutting portion comprising at least one cutting flute, and an intermediate portion connecting the shank to the cutting portion, the intermediate portion including at least one longitudinal slot. A depth gauge includes a body configured to receive the drill bit, a retention mechanism coupled to the body and having an inward projection to removably couple the body to the at least one additional slot in the drill bit, and a cap coupled to the body such that the cap contacts a workpiece surface to prevent the drill bit from entering the workpiece more than a predetermined depth, wherein the cap is movable relative to the body among a plurality of positions, wherein each of the plurality of positions corresponds to a different predetermined drilling depth.